Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Details
Download: 31213547_BIB_89AC1F96DED4.pdf (1915.55 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_89AC1F96DED4
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN
1091-6490 (Electronic)
ISSN-L
0027-8424
Publication state
Published
Issued date
02/07/2019
Peer-reviewed
Oui
Volume
116
Number
27
Pages
13490-13497
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Abstract
Resident fibroblasts at sites of infection, chronic inflammation, or cancer undergo phenotypic and functional changes to support leukocyte migration and, in some cases, aggregation into tertiary lymphoid structures (TLS). The molecular programming that shapes these changes and the functional requirements of this population in TLS development are unclear. Here, we demonstrate that external triggers at mucosal sites are able to induce the progressive differentiation of a population of podoplanin (pdpn)-positive stromal cells into a network of immunofibroblasts that are able to support the earliest phases of TLS establishment. This program of events, that precedes lymphocyte infiltration in the tissue, is mediated by paracrine and autocrine signals mainly regulated by IL13. This initial fibroblast network is expanded and stabilized, once lymphocytes are recruited, by the local production of the cytokines IL22 and lymphotoxin. Interfering with this regulated program of events or depleting the immunofibroblasts in vivo results in abrogation of local pathology, demonstrating the functional role of immunofibroblasts in supporting TLS maintenance in the tissue and suggesting novel therapeutic targets in TLS-associated diseases.
Keywords
Animals, Disease Models, Animal, Fibroblasts/pathology, Flow Cytometry, Fluorescent Antibody Technique, Humans, Interleukin-13/metabolism, Interleukins/metabolism, Lymphocytes/pathology, Mice, Salivary Glands/pathology, Tertiary Lymphoid Structures/pathology, Sjögren’s syndrome, autoimmunity, fibroblasts, tertiary lymphoid structures
Pubmed
Web of science
Open Access
Yes
Create date
24/06/2019 16:14
Last modification date
15/01/2021 7:10